Immune Systems Advisor

Dr. Peter McCullough is an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas, USA. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough Protocol 2022 Updates:  Double blind randomized controlled trial of saline solution gargling and nasal rinsing in COVID infection (Nov 2023) What really killed COVID-19 patients: It wasn't a cytokine storm, suggests study  (2023) Everyone is familiar with nasal and oral swab testing for COVID-19. It should be obvious the virus is replicating in the nose, and with Omicron, the speed of replication has become much greater than the pr...

If you've had COVID-19 or know someone who has, you've likely seen how the illness lingers. Unresolved fatigue, reduced physical capacity, and cognitive fog are common weeks or even months after the infection clears. In more severe cases, the virus left behind lasting damage to the kidneys, lungs, or vascular system. These outcomes are now recognized as long COVID. As attention shifts from short-term containment to long-term recovery, more researchers are focusing on the cellular pathways that support resilience after viral illness. One area drawing renewed attention is the use of nicotinamide adenine dinucleotide (NAD⁺), a molecule your cells use to produce energy, repair DNA, regulate inflammation, and maintain mitochondrial function. One of the most straightforward ways to raise NAD⁺ safely and effectively is through niacinamide, a common and inexpensive form of vitamin B3. Case in point, a new placebo-controlled trial published in Nature Metabolism has highlighted niacinami...

More than four years after COVID-19 first appeared, many people still suffer from long-lasting symptoms after getting infected. This ongoing condition was often called 'Long COVID'. It means symptoms stick around for three months or more after the infection or after exposure to certain COVID-19 vaccines that use mRNA technology. In late 2023, some researchers introduced a new name, "SPIKEOPATHY," to explain that a protein called the Spike protein—found in both the virus and mRNA vaccines—plays a big role in causing these long-term problems. Because of this, the term Post-Spike Syndrome (PSS) is suggested as a clearer name for this condition. What is Post-Spike Syndrome? PSS can affect many parts of the body and cause serious, long-lasting health problems. Scientists are learning more about how the Spike protein causes these issues. The tiny particles from mRNA vaccines can travel through the body, not just stay where the shot was given. Both these particles and the Sp...